首页/数据集/Opinion on the safety of pharmacological weight loss support in Poland 2024

Opinion on the safety of pharmacological weight loss support in Poland 2024

Statista2026-04-25 收录

药物安全性评估

减肥药物市场研究

数据链接：

https://www.statista.com/statistics/1489592/poland-safety-of-pharmacological-weight-loss-support/数据链接链接失效反馈

官方服务：

资源简介：

Opinion on the safety of pharmacological weight loss support in Poland in 2024

应用场景：

药物不良反应监测

药物安全性评估

This study analyzed adverse drug event (ADE) signals associated with metreleptin using the FDA Adverse Event Reporting System (FAERS) to provide insights for safe clinical use. Data from 1 January 201

DataCite Commons2026-05-04 更新120

Rates of systemic adverse effects of head-to-head studies (direct comparison).

药物安全性评估

癌症治疗不良反应

Nr: Not reported. *Data from CATT appendix: they refer to duodenal ulcer haemorrhage, gastric ulcer haemorrhage, (lower) gastrointestinal haemorrhage, rectal haemorrhage. #Rates refer mainly to pneumo

NIAID Data Ecosystem60

Local and Solicited Systemic Reactogenicity.

疫苗反应原性

药物安全性评估

Local and Solicited Systemic Reactogenicity.

NIAID Data Ecosystem40

Dataset from A Phase II Safety Study of TAK-375 in Subjects With Mild to Moderate Obstructive Sleep Apnea

药物安全性评估

阻塞性睡眠呼吸暂停

The purpose of this study is to assess the safety of ramelteon, once daily (QD), in individuals with obstructive sleep apnea.

NIAID Data Ecosystem80

DILI_Camenisch_Supplementary Table_Final.xlsx